Standardized extracts of Bacopa monniera protect against MPP+- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways

Toxicological Sciences

Volumn 125, Issue 1, 2012, Pages 219-232

  Singh, Manjeet ^a   Murthy, Ven ^b   Ramassamy, Charles ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Bacopa monniera; Complex I; Oxidative stress; Parkinson's disease; Redox regulation

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BACOPA MONNIERI EXTRACT; GLUTATHIONE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PARAQUAT; PROTEASOME; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BACOPA MONNIERI; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUROPROTECTION; OXIDATION REDUCTION REACTION; PARAQUAT POISONING; PARKINSON DISEASE; PREMEDICATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION;

BACOPA MONNIERI;

EID: 84555195332     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr255     Document Type: Article

References (80)

1. Alladi, P. A., Mahadevan, A., Yasha, T. C., Raju, T. R., Shankar, S. K., and Muthane, U. (2009). Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: Relevance to lower incidence of Parkinson's disease. Neuroscience 159, 236-245.
2. Anbarasi, K., Vani, G., and Devi, C. S. (2005). Protective effect of bacoside A on cigarette smoking-induced brain mitochondrial dysfunction in rats. J. Environ. Pathol. Toxicol. Oncol. 24, 225-234.
3. Bindokas, V. P., Jordan, J., Lee, C. C., and Miller, R. J. (1996). Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine. J. Neurosci. 16, 1324-1336.
4. Birch-Machin, M. A., and Turnbull, D. M. (2001). Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 65, 97-117.
5. Bishop, G. M., Dringen, R., and Robinson, S. R. (2007). Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic. Biol. Med. 42, 1222-1230.
6. Bonneh-Barkay, D., Langston, W. J., and Di Monte, D. A. (2005). Toxicity of redox cycling pesticides in primary mesencephalic cultures. Antioxid. Redox Signal. 7, 649-653.
7. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
8. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
9. Castello, P. R., Drechsel, D. A., and Patel, M. (2007). Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 282, 14186-14193.
10. Chakravarty, A. K., Sarkar, T., Masuda, K., Shiojima, K., Nakane, T., and Kawahara, N. (2001). Bacopaside, Bacopaside I and II: Two psedojujubogenin glycosides from B. monniera. Phytochem. Anal. 58, 553-556.
11. Chen, L. J., Gao, Y. Q., Li, X. J., Shen, D. H., and Sun, F. Y. (2005). Melatonin protects against MPTP/MPP+-induced mitochondrial DNA oxidative damage in vivo and in vitro. J. Pineal Res. 39, 34-42.
12. Cheng, W. H., Ho, Y. S., Valentine, B. A., Ross, D. A., Combs, G. F. J., and Lei, X. G. (1998). Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J. Nutr. 128, 1070-1076.
13. Chinta, S. J., and Andersen, J. K. (2006). Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: Implications for Parkinson's disease. Free Radic. Biol. Med. 41, 1442-1448.
14. Cleren, C., Calingasan, N. Y., Chen, J., and Beal, M. F. (2005). Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J. Neurochem. 94, 995-1004.
15. Copple, I. M., Goldring, C. E., Kitteringham, N. R., and Park, B. K. (2008). The Nrf2-Keap1 defence pathway: Role in protection against drug-induced toxicity. Toxicology 246, 24-33.
16. Cuadrado, A., Moreno-Murciano, P., and Pedraza-Chaverri, J. (2009). The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease. Expert Opin. Ther. Targets 13, 319-329.
17. Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005). Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci. U.S.A. 102, 4584-4589.
18. Domingues, A. F., Arduíno, D. M., Esteves, A. R., Swerdlow, R. H., Oliveira, C. R., and Cardoso, S. M. (2008). Mitochondria and ubiquitinproteasomal system interplay: Relevance to Parkinson's disease. Free Radic. Biol. Med. 45, 820-825.
19. Drechsel, D. A., and Patel, M. (2009). Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism. Toxicol. Sci. 112, 427-434.
20. Drechsel, D. A., Liang, L. P., and Patel, M. (2007). 1-Methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons. Toxicol. Appl. Pharmacol. 220, 341-348.
21. Endo, R., Saito, T., Asada, A., Kawahara, H., Ohshima, T., and Hisanaga, S. (2009). Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator. J. Biol. Chem. 284, 26029-26039.
22. Flohé, L., and Günzler, W. A. (1984). Assays of glutathione peroxidase. Methods Enzymol. 105, 114-121.
23. Gao, Q. G., Chen, W. F., Xie, J. X., and Wong, M. S. (2009). Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J. Neurochem. 109, 1338-1347.
24. Gardaneh, M., Gholami, M., and Maghsoudi, N. (2011). Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine. Rejuvenation Res. 14, 195-204.
25. Garrido, M., Tereshchenko, Y., Zhevtsova, Z., Taschenberger, G., Bähr, M., and Kügler, S. (2011). Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons. Acta Neuropathol. 121, 475-485.
26. Graham, D. G. (1978). Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
27. Griffith, W. O. (1999). Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27, 922-935.
28. Habig, H. W., Pabst, J. M., and Jakoby, B. W. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
29. Harvey, C. J., Thimmulappa, R. K., Singh, A., Blake, D. J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A., and Biswal, S. (2009). Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic. Biol. Med. 46, 443-453.
30. Hastings, T. G. (2009). The role of dopamine oxidation in mitochondrial dysfunction: Implications for Parkinson's disease. J. Bioenerg. Biomembr. 41, 469-472.
31. Hatcher, J. M., Pennell, K. D., and Miller, G. W. (2008). Parkinson's disease and pesticides: A toxicological perspective. Trends Pharmacol. Sci. 29, 322-329.
32. Hota, S. K., Barhwal, K., Baitharu, I., Prasad, D., Singh, S. B., and Ilavazhagan, G. (2009). Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol. Dis. 34, 23-39.
33. Howes, M. J., and Houghton, P. J. (2003). Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol. Biochem. Behav. 75, 513-527.
34. Huang, J. Y., and Chuang, J. I. (2010). Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity. Free Radic. Biol. Med. 49, 1099-1108.
35. Hwang, P. Y., and Jeong, G. H. (2010). Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol. Appl. Pharmacol. 242, 18-28.
36. Ikeyama, S., Kokkonen, G., Shack, S., Wang, X. T., and Holbrook, N. J. (2002). Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities. FASEB J. 16, 114-116.
37. Jenner, P. (1993). Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol. Scand. 146, 6-13.
38. Jenner, P. (1998). Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13, 24-34.
39. Jiang, H., Jiang, Q., and Feng, J. (2004). Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J. Biol. Chem. 279, 54380-54386.
40. Kensler, W. T., Wakabayashi, N., and Biswal, S. N. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116.
41. Lang, A. E., and Lozano, A. M. (1998). Parkinson's disease. N. Engl. J. Med. 339, 1044-1053.
42. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
43. Lee, J. M., Shih, A. Y., Murphy, T. H., and Johnson, J. A. (2003). NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278, 37948-37956.
44. Lotharius, J., and O'Malley, K. L. (2000). The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275, 38581-38588.
45. McCormack, A. L., and Di Monte, D. A. (2003). Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J. Neurochem. 85, 82-86.
46. McNaught, K. S., Belizaire, R., Isacson, O., Jenner, P., and Olanow, C. W. (2003). Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38-46.
47. Moretto, A., and Colosio, C. (2011). Biochemical and toxicological evidence of neurological effects of pesticides: The example of Parkinson's disease. Neurotoxicology 32, 383-391.
48. Murthy, P. B., Raju, V. R., Ramakrisana, T., Chakravarthy, M. S., Kumar, K. V., Kannababu, S., and Subbaraju, G. V. (2006). Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem. Pharm. Bull. (Tokyo) 54, 907-911.
49. Muthane, U., Yasha, T. C., and Shankar, S. K. (1998). Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann. Neurol. 43, 283-287.
50. Nathan, P. J., Clarke, J., Lloyd, J., Hutchison, C. W., Downey, L., and Stough, C. (2001). The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects. Hum. Psychopharmacol. 16, 345-351.
51. Phrompittayarat, W., Wittaya-areekul, S., Jetiyanon, K., Putalun, W., Tanaka, H., and Ingkaninan, K. (2008). Stability studies of saponins in Bacopa monnieri dried ethanolic extracts. Planta Med. 74, 1756-1763.
52. Przedborski, S. (2005). Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat. Disord. 11, S3-S7.
53. Przedborski, S., Tieu, K., Perier, C., and Vila, M. (2004). MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36, 375-379.
54. Ramsay, R. R., and Singer, T. P. (1986). Energy-dependent uptake of Nmethyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3,6-tetrahydropyridine, by mitochondria. J. Biol. Chem. 261, 7585-7587.
55. Richardson, J. R., Quan, Y., Sherer, T. B., Greenamyre, J. T., and Miller, G. W. (2005). Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol. Sci. 88, 193-201.
56. Ridet, J. L., Bensadoun, J. C., Déglon, N., Aebischer, P., and Zurn, A. D. (2006). Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's disease. Neurobiol. Dis. 21, 29-34.
57. Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. (1989). Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
58. Russo, A., and Borrelli, F. (2005). Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine 12, 305-317.
59. Salinas, M., Martín, D., Alvarez, A., and Cuadrado, A. (2001). Akt1/PKBalpha protects PC12 cells against the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals. Mol. Cell. Neurosci. 17, 67-77.
60. Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., and Marsden, C. D. (1989). Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
61. Schildknecht, S., Pöltl, D., Nagel, D. M., Matt, F., Scholz, D., Lotharius, J., Schmieg, N., Salvo-Vargas, A., and Leist, M. (2009). Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol. Appl. Pharmacol. 241, 23-35.
62. Shen, D., Dalton, T. P., Nebert, D. W., and Shertzer, H. G. (2005). Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 280, 25305-25312.
63. Shi, M., Bradner, J., Bammler, T. K., Eaton, D. L., Zhang, J., Ye, Z., Wilson, A. M., Montine, T. J., Pan, C., and Zhang, J. (2009). Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am. J. Pathol. 175, 54-65.
64. Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., and Sonntag, K. C. (2009). Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson's disease pathology. Brain 132, 1795-1809.
65. Singh, H. K., Rastogi, R. P., Sriman, R. C., and Dhawan, B. N. (1988). Effect of bacoside A and B on avoidance response in rats. Phytother. Res. 2, 70-75.
66. Singh, H. K., and Dhawan, B. N. (1982). Effect of Bacopa monniera Linn. (Brahmi) extract on avoidance responses in rat. J. Ethnopharmacol. 5, 205-214.
67. Singh, M., Murthy, V., and Ramassamy, C. (2010). Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the bacopa monniera extract: Potential implication in Alzheimer's disease. J. Alzheimers Dis. 21, 229-247.
68. Stough, C., Lloyd, J., Clarke, J., Downey, L. A., Hutchison, C. W., Rodgers, T., and Nathan, P. J. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl.) 156, 481-484.
69. Smeyne, M., Boyd, J., Raviie Shepherd, K., Jiao, Y., Pond, B. B., Hatler, M., Wolf, R., Henderson, C., and Smeyne, R. J. (2007). GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 104, 1977-1982.
70. Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R. M., and Hagen, T. M. (2004). Decline in transcriptional activity of Nrf2 causes agerelated loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. U.S.A. 101, 3381-3386.
71. Sulzer, D. (2007). Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30, 244-250.
72. Sumathy, T., Govindasamy, S., Balakrishna, K., and Veluchamy, G. (2002). Protective role of Bacopa monniera on morphine-induced brain mitochondrial enzyme activity in rats. Fitoterapia 73, 381-385.
73. Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011). Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 119, 866-872.
74. Timmons, S., Coakley, M. F., Moloney, A. M., and O'Neill, C. (2009). Akt signal transduction dysfunction in Parkinson's disease. Neurosci. Lett. 467, 30-35.
75. Trott, A., West, J. D., Klaić, L., Westerheide, S. D., Silverman, R. B., Morimoto, R. I., and Morano, K. A. (2008). Activation of heat shock and antioxidant responses by the natural product celastrol: Transcriptional signatures of a thiol-targeted molecule. Mol. Biol. Cell 19, 1104-1112.
76. Wu, X. F., Block, M. L., Zhang, W., Qin, L., Wilson, B., Zhang, W. Q., Veronesi, B., and Hong, J. S. (2005). The role of microglia in paraquatinduced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7, 654-661.
77. Yang, L., Calingasan, N. Y., Thomas, B., Chaturvedi, R. K., Kiaei, M., Wille, E. J., Liby, K. T., Williams, C., Royce, D., Risingsong, R., et al. (2009). Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One 4, e5757.
78. Zhou, Z. D., and Lim, T. M. (2009). Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones. Free Radic. Res. 43, 417-430.
79. Zhu, Y., Carvey, M. P., and Ling, Z. (2006). Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 1090, 35-44.
80. 2+. J. Biol. Chem. 279, 4166-4174.